Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | -34,473 | 6,267 | 32,682 | 94 | 0 |
| Operating Income | 34,473 | -6,267 | -32,682 | -94 | N/A |
| Other Income | 35 | -21 | -4 | 18 | 0 |
| Pre-tax Income | 34,508 | -6,288 | -32,686 | -76 | 0 |
| Net Income Continuous | 34,508 | -6,288 | -32,686 | -76 | N/A |
| Net Income | $34,508 | $-6,288 | $-32,686 | $-76 | $N/A |
| EPS Basic Total Ops | 5.25 | -2.63 | -2.90 | -0.03 | N/A |
| EPS Basic Continuous Ops | 3.97 | -2.63 | -2.90 | -0.03 | N/A |
| EPS Diluted Total Ops | 5.25 | -2.63 | -2.90 | -0.03 | N/A |
| EPS Diluted Continuous Ops | 3.97 | -2.63 | -2.90 | -0.03 | N/A |
| EBITDA(a) | $34,473 | $-6,265 | $-32,682 | $-94 | $N/A |